Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.
about
Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neuronsNeuroanatomy goes viral!Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccineA single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodiesInvestigating the role for IL-21 in rabies virus vaccine-induced immunity.Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA VirusesInactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.New rabies virus variants for monitoring and manipulating activity and gene expression in defined neural circuitsRabies virus nucleoprotein as a carrier for foreign antigens.A role for granulocyte-macrophage colony-stimulating factor in the regulation of CD8(+) T cell responses to rabies virus.Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection.A recombinant rabies virus carrying GFP between N and P affects viral transcription in vitro.PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity.Polyvalent AIDS vaccines.B cell infection and activation by rabies virus-based vaccines.ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo.One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeuticsRabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV.Production of glycoprotein-deleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons.APRIL:TACI axis is dispensable for the immune response to rabies vaccination.Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity.Axonal and subcellular labelling using modified rabies viral vectors.Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity.
P2860
Q24646447-9FC24B13-3224-46DB-B157-E967158F1CB9Q26802140-EB11BB4C-33E4-409F-AF3A-5E089AE4EFA6Q27334697-C1C0AB13-B090-4BE5-A38F-5E7A3348D97EQ34338054-A5525EBF-8F1D-4C13-9D8D-BD57C8463170Q34630598-F9531375-B962-4728-8190-FC3ABAC71DB0Q34806497-5E7312BA-5327-480D-A3F3-00E1816E9ADFQ35275167-ED797CAD-D0C0-4757-91E2-9688EEA00C27Q35293727-0D594CB7-880B-4E70-8C8E-7E3974690A49Q35320069-4F11C29F-6E56-448E-93E9-8E7D4AA8D355Q35803316-52816043-6754-42EB-973A-C434962C2A3EQ36073443-4A9AD1AC-5AB0-4099-AA4E-F78629925EB2Q36363223-FF1BF5D6-527D-4B82-87B4-750C62483ED2Q36874768-631A6B34-6302-44F1-9E07-744F7857D3B4Q36898934-4A68FF79-3701-4976-BB3E-144A1DB88BA0Q37094429-61D60D83-F58F-43E0-8E28-41C1AADE122DQ37123384-5E11A4DE-74D3-417D-9B31-97723E126422Q37529574-73D57B0A-56C1-4013-B3E6-4F94E8136B99Q37560824-ECFBAA15-0E94-4DBB-AF6A-8FAE1EC19626Q38363535-931EFF2C-9BAB-49F7-91F3-0D0ACE2B5738Q39633419-6DE85CE3-93AF-4C04-B2F1-94AAD54130DAQ39732172-1EB0E5E9-3A1E-4F34-A1B7-CCA21B8D3165Q40158110-D5720F45-87F4-454A-AC1D-931AE89C1388Q40355293-DCA9B98F-BE62-4918-BCDA-7F2580D22969Q41217724-A0DCCA83-2ABF-45ED-9927-E9975E1B15FCQ42276697-A1B238DE-0E0D-4BC3-8E23-564E000E8305Q43178486-4648FD3C-5B11-499E-98AB-B7AC86516A87
P2860
Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Functional human immunodeficie ...... s-based vaccine vector genome.
@ast
Functional human immunodeficie ...... s-based vaccine vector genome.
@en
type
label
Functional human immunodeficie ...... s-based vaccine vector genome.
@ast
Functional human immunodeficie ...... s-based vaccine vector genome.
@en
prefLabel
Functional human immunodeficie ...... s-based vaccine vector genome.
@ast
Functional human immunodeficie ...... s-based vaccine vector genome.
@en
P2093
P2860
P1433
P1476
Functional human immunodeficie ...... s-based vaccine vector genome.
@en
P2093
James P McGettigan
Jan Orenstein
Kristin Naper
Martin Koser
Matthias J Schnell
Philip M McKenna
P2860
P304
10889-10899
P356
10.1128/JVI.77.20.10889-10899.2003
P407
P577
2003-10-01T00:00:00Z